AAIC 2025 - Alzheimer's Association International Conference®

Neurodegeneration
-
Toronto
,
Canada

We will be present at this event, booth #622. We will be hosting a product theater, Blood-Based Breakthrough: Improving Access to Amyloid Pathology Evaluation with FDA-Cleared Plasma pTau 217/ AB 1-42 Ratio Test on Monday, July 28 at 10:35 a.m. Product Theater Stage #2 (Front of the 1600 Aisle on the Exhibit Floor).

Please contact us if you have any questions or would like to schedule a meeting with a Fujirebio representative.

Request a meeting at this event

Please fill in the form below to request a meeting with one of our team members.

CAPTCHA

The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.